ABSTRACT ␣2-Adrenergic receptor (␣ 2 -AR) activation in the pregnant rat myometrium at midterm potentiates ␤ 2 -AR stimulation of adenylyl cyclase (AC) via G␤␥ regulation of the type II isoform of adenylyl cyclase. However, at term, ␣ 2 -AR activation inhibits ␤ 2 -AR stimulation of AC. This phenomenon is associated with changes in ␣ 2 -AR subtype expression (midterm 32 P]GTP-labeling of activated G proteins indicated that, in ␣ 2B -AR transfectants, clonidine activated only Gi 2 , whereas epinephrine, the full agonist, effectively coupled to Gi 2 and Gi 3 . Thus, partial and full agonists selectively activate G proteins that lead to drug specific effects on effectors. Moreover, these data indicate that Gi 3 activation is required for potentiation of ␤ 2 -AR stimulation of AC by ␣ 2A/D and ␣ 2B -AR in DDT1-MF2 cells. This may reflect an issue of the amount of G␤␥ released upon receptor activation and/or ␤␥ composition of Gi 3 versus Gi 2 .
In pregnant rat myometrium, ␣ 2 -adrenoceptor (AR) signaling pathways differentially modulate ␤ 2 -AR-mediated regulation of adenylyl cyclase (AC) at midpregnancy and at term . At midterm, ␣ 2 -AR activation potentiates adenylyl cyclase activity stimulated by ␤ 2 -AR, thus enhancing uterine relaxation in response to catecholamines. This augmentation of AC activity induced by ␣ 2 -AR probably involves the type II family isoform of AC and is caused by the input of G␤␥ released from Gi (Gi 2 and/or Gi 3 ) that synergizes with Gs to further elevate cAMP levels . In contrast, at term, myometrial ␣ 2 -AR/Gi signaling pathways reduce the ␤ 2 -AR-induced-cAMP generation to allow intracellular Ca 2ϩ increase and cell contraction. This switch in the stimulatory versus inhibitory input to ␤ 2 -ARdependent cAMP generation that occurs between mid-and late pregnancy may be influenced by changes in the expression of AC isoforms, G proteins, and/or ␣ 2 -AR subtypes expression.
When comparing mid-and late pregnancy, no substantial modification in the amounts of specific types of AC transcripts and no alteration in the basal activity of the AC system could be found. In particular, the expression of transcripts encoding for members of AC type II family, which are involved in this potentiation process, persisted throughout the time course of pregnancy up to parturition . Conversely, as shown by pharmacological data and Northern blot analysis , the two ␣ 2 -AR subtypes expressed in rat myometrium, ␣ 2A -and ␣ 2B -AR, were differentially expressed at midpregnancy and term (midpregnancy ␣ 2A/D -AR Ͼ Ͼ ␣ 2B -AR; term ␣ 2B Ն ␣ 2A/D -AR). Also, significant changes in the Gi 2 /Gi 3 ratio could be detected by immunoblot analysis (Tanfin et al., 1991; CohenTannoudji et al., 1995) . Altogether, these data suggested that the switch of regulation mediated by ␣ 2 -adrenoceptors toward ␤ 2 -dependent cAMP production could result from a specific signaling of ␣ 2 -AR subtypes toward AC II activity and/or alteration in receptor coupling to G proteins.
As an initial approach, we used DDT1-MF2 (hamster vas deferens smooth muscle cell) cotransfectants stably expressing ␣ 2A/D -AR (RG20) or ␣ 2B -AR (␣ 2 C2) and AC type II isoform and studied the regulation induced by each ␣ 2 -AR subtypes on ␤ 2 -stimulated AC II activity. We report, herein, agonist and receptor specific regulation of ACII that involves selective coupling to Gi 2 versus Gi 3 . Our results also shed light upon molecular mechanism by which clonidine acts as a partial agonist through ␣ 2B -AR. (Meudon, France) . GF/C glass-fiber filters were from Millipore (Saint Quentin en Yvelines, France). All remaining drugs were from SigmaAldrich (Saint Quentin Fallavier, France).
Materials and Methods
Cell Culture and Transfection. DDT1-MF2 cells were grown and stably transfected with human ␣ 2B (␣ 2 C2) or rat ␣ 2A/D (RG20) cDNA as described previously (Duzic and Lanier, 1992 ). Resistant clones were tested for their ␣ 2 -AR binding capacity using the selective tritiated antagonist [ 3 H]rauwolscine as described under binding studies. Clones expressing a receptor density between 1 and 1.5 pmol/mg of membrane proteins, were further cotransfected with the ACII cDNA expression vector and the drug resistance cassette pHyg according to the transfection strategy described by Gorman (1986) . Transfected cells were selected by their resistance to hygromycin B (750 mg/ml). Each clone was then analyzed for AC II expression by Northern blot using a 32 P-labeled cDNA AC II probe [rat full-length (4 kilobases)] as described previously (Marjamaki et al., 1997) and tested for enzyme activity.
Partially Purified Membrane Preparation. Membranes were prepared by hypotonic lysis in ice-cold lysis buffer (5 mM Tris-HCl, pH 7.5, 5 mM EDTA, 5 mM EGTA, 0.1 mM phenylmethylsulfonyl fluoride, 10 mg/ml aprotinin, and 10 mg/ml pepstatin A) and collected by centrifugation (17,000g for 15 min at 4°C). Membrane pellet was resuspended in 50 mM HEPES, pH 8.0, for adenylyl cyclase assay or 50 mM Tris, pH 7.5, 5 mM MgCl 2 , 0.6 mM EDTA for binding studies. Protein concentration was determined according to the method of Schacterle and Pollack (1973) using bovine serum albumin as standard.
Binding Studies. For saturation experiments, membranes (30-40 g) were incubated with the required concentrations of [ 3 H]rauwolscine [1-50 nM] for 20 min at 25°C in a final volume of 100 l. Nonspecific binding was determined in the presence of 10 M phentolamine. Competition studies were performed in presence of increasing concentrations (10 pM-50 M) of various competitors and 8 nM [
3 H]rauwolscine (a concentration near the K D value). Bound radioligand was separated from the free by vacuum filtration over GF/C glass-fiber filters as described previously . Radioactivity was counted by liquid scintillation in a 1214 Rack-␤ spectrometer (LKB, Rockville, MD) with a counting efficiency of approximately 30%.
Data for saturation and competition studies were analyzed by a nonlinear least-squares, curve-fitting GraphPad program (Graph Pad Software, San Diego, CA). Iterative curve fitting to experimental data from one site model provided IC 50 . IC 50 were converted to K i values using the equation of Cheng and Prussof (1973) .
Adenylyl Cyclase Assay and Determination of Intracellular cAMP Accumulation. Adenylyl cyclase activity was measured as described previously (E. Duzic and S.M. Lanier, 1992) using 50 g of crude membrane. For intracellular cAMP accumulation, cells were plated at a concentration of 5 ϫ 10 5 cells/well in six-well plates and incubated at 37°C for 24 h. One hour before starting the experiment, the medium was removed and replaced with 4 ml of serum-free DMEM containing 20 mM HEPES, pH 7.5, and 250 mM isobutyl-Lmethylxanthine. Then, cells were incubated with drugs to be tested for 10 min at 37°C. The reaction was stopped by aspiration of the medium and cells were disrupted by the addition of 1 ml of 10% ice-cold trichloracetic acid per well. After recovering the cellular lysate by scrapping the wells, samples were centrifuged (10,000g, 15 min at 4°C). The supernatants were then extracted 3 times with diethyl ether (1v/4v) and cAMP contents were determined by a cAMP radioimmunoassay system obtained from NEN Life Sciences Products.
Immunoblot and Immunoprecipitation. For immunoblotting, 50 g of membranes obtained from DDT1-MF2 cells or tissues were resolved on 10% SDS-PAGE and transfer to polyvinylidene difluoride-transfer membrane POLYSCREEN (NEN Research Products, DuPont de Nemours, France). After transfer, the blots were probed with anti-G␣ protein subtype specific antibodies as described previously . Briefly, after blocking, the polyvinylidene difluoride blots were incubated with the primary antibody [AS/7 (anti-Gi␣ 2 /Gi␣ 1 ) or EC/2 (anti-Gi␣ 3 /G␣) or GC/2 (anti-G␣)] for 1 h in a high-detergent 5% nonfat dry milk/Trisbuffered saline at room temperature at a dilution of 1:1000. After four successive washes, the blots were incubated for 1 h with HRPconjugated secondary antibody in high-detergent 5% nonfat dry milk/Tris-buffered saline. After washing, bound antibodies were visualized using enhanced chemiluminescence reagents (Amersham Pharmacia Biotech, les Ulis, France). For immunoprecipitation, antisera were raised against the C-terminal decapeptide (amino acids 345-354) of Gi␣ 3 and against the C-terminal decapeptide (amino acids 345-354) that is shared by both Gi␣ 1 and Gi␣ 2 as described previously (Gettys et al., 1994) . The antisera were characterized with respect to titer, specificity, and cross-reactivity using lysates from bacteria transformed with cDNA for each of the G proteins. Each antiserum was desalted and purified as described previously (Raymond et al., 1993; Gettys et al., 1994) .
Photolabeling of Membrane G Proteins. The 4-azidoanilido-[␣-32 P]GTP ([␣-
32 P]AA-GTP) was synthesized according to the method described by Offermanns et al., 1990 and , except that [␣-
32 P]AA-GTP was purified using a thin-layer chromatography and finally resuspended in water at a concentration of 4 ϫ 10 9 cpm/ml. Photoaffinity labeling of G proteins was performed as described by Offermanns et al. (1991) . Briefly, cell membranes (50 g) were preincubated with ␣ 2 -AR agonists and/or antagonists for 10 min at 30°C in 50 l of assay buffer containing 30 mM HEPES, pH 7.5, 100 mM NaCl, 100 mM EDTA, 1 mM benzamidine, 5 mM MgCl 2, 50 mM leupeptin, and 3 M GDP. Then, 10 l of [␣-32 P]AA-GTP (0.4 ϫ 10 9 cpm/ml) diluted in distilled water was added to each sample and the labeling reaction was allowed to proceed for 10 min. The reaction was stopped by the addition of 100 l of ice-cold assay buffer and immediate 4°C centrifugation at 12,000g for 10 min. All subsequent procedures were performed at 4°C. Supernatants containing free [␣-
32 P]AA-GTP were removed. Membrane pellets were rapidly resuspended in 55 l of assay buffer supplemented with 2 mM dithiothreitol and exposed, on ice, to UV light (254 nm, 15 W) in the dark for 4 min. Before immunoprecipitation, photolabeled membranes (50 l) were then solubilized by incubation in presence of 0.25% SDS at 60°C for 5 min and addition of 50 l of an immunoprecipitation buffer (0.5% SDS, 2% Nonidet P40, 1% cholate, 150 mM NaCl). Solubilized samples were first incubated 30 min at 4°C with prewashed Pansorbin cells (25 l of a 10% solution in 50 mM sodium phosphate, pH 7.4) to further minimize the nonspecific antibody binding. After removing Pansorbin cells by centrifugation (700 g), each sample was divided in two aliquots and incubated in presence of anti-Gi␣ 2 or -Gi␣ 3 IgG (1:50) over night at 4°C under constant rotation. The immunocomplexes were collected by the addition of 25 l of Pansorbin cell suspension and centrifugation at 700g. Then, pellets were washed two times in PBS and resuspended in 30 l of 1.5% SDS and 30 l of Laemmli buffer (Laemmli, 1970) . Samples were boiled for 5 min before 10% SDS-PAGE analysis. After drying the gel, photolabeled proteins were visualized by autoradiography on Kodak X-Omat AR-5 films (Sigma-Aldrich). Incorporation of [␣-32 P]AA-GTP into immunoprecipitated G proteins ␣ subunits was quantified by densitometric analysis of autoradiograms with an Imstar computer-assisted image analyzer. Results are expressed as -fold incorporation of [␣-
32 P]AA-GTP into immunoprecipitated G protein ␣ subunits compared with unstimulated control subunits.
Results
Establishment of the Experimental System. DDT1-MF2 cells express useful common and distinct signaling entities in comparison with pregnant myometrium. Indeed, they display a similar density of ␤ 2 adrenoceptors and Gs proteins (Hadcock et al., 1991; Vivat et al., 1992) . They also express the same isoforms of pertussis toxin (PTX)-sensitive G proteins (Gi 2 and Gi 3 ) that exert a similar tonic inhibition of adenylyl cyclase activity in an agonist-independent manner (Tanfin et al., 1991; Cohen-Tannoudji et al., 1995) . However, none of ␣ 2 -AR subtypes (Philippe et al., 1989; Duzic and Lanier, 1992) nor AC isoforms type II and IV could be detected (Marjamaki et al., 1997 3 H]rauwolscinespecific binding was inhibited by subtype-selective compounds such as oxymetazoline (␣ 2A -specific), chlorpromazine and ARC 239 (␣ 2B -specific) with pK i values characteristic of human ␣ 2B -AR (Bylund et al., 1988) , thus indicating that the transfected ␣ 2B -AR receptors displayed the expected ligand recognition properties. The ␣ 2 -AR selective agonist clonidine inhibited the ␤ 2 -AR-stimulated-cAMP production in a dosedependent manner (significant at concentrations as low as 1 nM, *p Ͻ 0.05) (Fig. 1B) . This inhibitory effect was mediated through ␣ 2B -AR, because it was prevented by the ␣ 2 -AR antagonist yohimbine and was not observed in cells transfected with vector alone. Incubation of the cells with PTX completely abolished the inhibition of stimulated cAMP accumulation elicited by the activation of the expressed ␣ 2B -AR (data not shown). Maximal reduction of the isoproterenol response was 59% Ϯ 6 (EC 50 value of ϳ 30 nM). These additional data indicated that, besides retaining its binding features, ␣ 2B -AR expressed in the plasma membranes of DDT1-MF2 cells was functional and implicated in a negative cross talk with the ␤ 2 -AR/Gs cascade through PTX-sensitive G proteins.
DDT1-MF2 cells expressing ␣ 2B -AR and ␣ 2A/D -AR were further stably cotransfected with the cDNA encoding adenylyl cyclase II isoform. RNA screening using AC II cDNAspecific probe indicated that transcripts of expected 4.2-kilobase size were detected in selected hygromycin resistant Effect of ␣2-AR Activation on Cellular cAMP in DDT1-MF2 Cotransfectants. Whereas epinephrine stimulation potentiated the ␤ 2 -activated cAMP production in DDT1-MF2-␣ 2B -ACII cotransfectants, clonidine decreased it (Fig. 3A) . Indeed, epinephine enhanced ␤ 2 -stimulated cAMP production up to 52% Ϯ 2 at 10 M with an ED 50 value of 114 Ϯ 33 nM. Conversely, clonidine produced a dose-dependent attenuation of cAMP accumulation over a concentration range of 1 nM to 0.1 mM. Maximal inhibition (Ϫ43%) was obtained at 1 M (*p Ͻ 0.05). Half-maximal inhibition (ED 50 ) occurred at 10 nM clonidine. With higher concentrations of clonidine, negative input persisted, although it was reduced. The inhibitory influence of the clonidine-activated ␣ 2B -AR did not seem to be caused by low receptor expression in ␣ 2B -ACII cells. Indeed, in these cells, B max was 1.3 Ϯ 1 pmol of receptor/mg of membrane protein, a receptor density equivalent to the one measured in ␣ 2A/D -ACII cells (1.2 Ϯ 0.045 pmol/mg). Furthermore, we tested six ␣ 2B -ACII clones ranging in receptor density from 1 to 3 pmol/mg of protein; none produced significant potentiation of isoproterenol-stimulated cAMP accumulation using clonidine (data not shown). Conversely, they all reduced cAMP-␤ 2 -AR dependent generation. These data demonstrated that in DDT 1 -MF 2 cells expressing type II AC isoform, the ␣ 2B -AR could translate into opposite response depending on the type of agonist used (epinephrine or clonidine).
In contrast to the divergent agonist effects observed in ␣ 2B -AC II cotransfectants, both clonidine and epinephrine increased isoproterenol-stimulated cAMP production in ␣ 2A/D -AC Data are expressed as the percentage of isoproterenol-stimulated cAMP production (control ϭ 100%). Results are the mean Ϯ S.E. of three independent determinations performed in duplicate. The dose-response significance as well as dose-response curve differences were analyzed by one-way analysis of variance followed by Bonferroni's multiple range test. II cotransfectants (Fig. 3B) . The maximal stimulation of cAMP accumulation was produced at 0.1 M clonidine (60 Ϯ 1%) and 1 M epinephrine (115 Ϯ 41%). ED 50 values were 9 Ϯ 1.3 and 180 nM Ϯ 48 nM, respectively.
In both cotransfectants (␣ 2B -ACII and ␣ 2A/D -ACII), clonidine as well as epinephrine effects were blocked by yohimbine (Fig. 3, A and B) and prior treatment of cells with PTX (Fig. 4) . These data were consistent with the fact that these two agonists potentiated or inhibited cAMP production acting on ␣ 2 -ARs through Gi/o family members endogenously expressed in DDT1-MF2. However, epinephrine also produced a small PTX-insensitive potentiation of cAMP levels when acting through ␣ 2B -AR. One possible interpretation of this result is that ␣ 2B -AR, when present in high density in the membrane, may also cross-react, to a low extent, with endogenous Gs proteins, as reported previously in other cell lines (Eason et al., 1992 (Eason et al., , 1994 Pepperl and Regan, 1993) .
Altogether, these results indicated that, in the presence of transfected AC II, ␣ 2B -AR was able to mediate opposite regulatory effects (positive input versus negative input) on Gsstimulated cAMP production via PTX-sensitive G proteins. To gain insight on how ␣ 2B -AR could switch from a positive to a negative regulation, we compared Gi protein coupling of epinephrine-and clonidine-activated ␣ 2 -AR subtypes. (Fig. 5) (Hadcock et al., 1991; Tanfin et al., 1991 . Thus, agonist-specific adenylyl cyclase II response could be the consequence of a differential ␣ 2 -AR subtype specific recruitment of Gi 2 and/or Gi 3 . So, we questioned whether the differences observed in the receptor coupling to AC for clonidine and epinephrine in the cell models reflected specific coupling to Gi 2 or Gi 3 . This issue was addressed by incubation of membranes with the photoreactive GTP analog, 4-azido-anilido-[␣Ϫ 32 P]GTP ([␣-32 P]AA-GTP) in the presence of ligand, followed by cross-linking, solubilization, and selective immunoprecipitation of Gi 2 or Gi 3 .
Selective Recruitment of Gi Proteins by
As shown in Fig. 6A , clonidine induced a dose-dependent labeling of Gi␣ 2 protein exclusively. No significant incorporation of [␣-
32 P]AA-GTP was detected in Gi␣ 3 protein. At 1 M clonidine, maximal labeling of G␣i 2 with [␣-P 32 ]ϪAA-GTP (ϳ 2.5-fold compared with control fraction) was completely inhibited with yohimbine, thus indicating that recruitment of Gi␣ 2 protein was strictly dependent upon ␣ 2B -AR activation. It should be noted that 1 M clonidine elicited maximal inhibition of Gs-stimulated cAMP production (Fig. 3A) . In marked contrast, when experiments of similar design were conducted with epinephrine, both G␣i proteins (Gi␣ 2 and Gi␣ 3 ) were photolabeled (Fig. 6B) . Maximal incorporation of [␣-
32 P]AA-GTP was obtained at 1 M epinephrine for each endogenous Gi protein (ϳ2.6-fold compared with control fraction). This epinephrine-dependent [␣-32 P]GTP azidoanilide labeling resulted from ␣ 2B -AR activation, because it could be completely blocked by yohimbine. On membranes obtained from DDT1-MF2-␣ 2A/D -ACII cotransfectants where AC II potentiation also occurred, clonidine induced activation of both types of Gi proteins [ϳ2.6-and 2-fold, respectively, for G␣i 2 and G␣i 3 proteins compared with unstimulated fraction at 1 M (Fig. 7) ].
Altogether, these data indicated that Gi 3 activation is required for potentiation of ␤ 2 -AR stimulation of AC II by ␣ 2A/D -or ␣ 2B -AR in DDT1-MF2 cells. Furthermore, they suggested that heterotrimeric Gi2 and Gi3 proteins may have specific roles in modulating stimulated AC II activity in a given cell type.
Discussion
Activation of ␣ 2 -AR subtypes induces multiple cellular effects, including inhibition of adenylyl cyclase or, in some Fig. 4 . Effect of clonidine or epinephrine on isoproterenol-stimulated cAMP production in DDT1-MF2-␣ 2B -AC II or ␣ 2A/D -AC II cotransfectants after cell preincubation in presence or absence of PTX. Confluent plates of cells were pretreated with pertussis toxin (100 ng/ml) or vehicle for 18 h at 37°C in normal culture medium. Cells were further incubated with isoproterenol (1 M) in the absence and presence of clonidine (1 M) or epinephrine (1 M) for 10 min at 37°C. Data are expressed as percentage inhibition or augmentation of isoproterenol-induced elevation of cAMP production and represent the mean Ϯ S.E. of three to six separate experiments performed in duplicate. Values obtained in the presence and absence of pertussis toxin were compared using an unpaired Student's t test. *Statistically significant difference (p Ͻ 0.05).
Fig. 5.
Identification of G␣i and Go␣ proteins in DDT1-MF2 cotransfectants cell membranes. Immunoblotting was performed with antibodies directed against G␣i1 and G␣i 2 (AS/7), G␣i 3 and G␣o (EC/2), or Go␣ (GC/2) as described under Materials and Methods. Br is used for rat brain, DDT1 for DDT1-MF2 cells, and Myo for rat pregnant myometrium. Molecular masses (kDa) of protein are given next to molecular size markers.
physiological models or cell systems, an increase of cAMP levels. The mechanisms responsible for inhibitory or stimulatory input on adenylyl cyclase activity/cAMP production greatly depend on their interaction with PTX-sensitive G inhibitory proteins and, additionally, also reflect the type of adenylyl cyclases expressed in various cells.
The present work was motivated by the observation that, in the midpregnancy and term myometrium, the cross talk between activated ␣ 2 -and ␤ 2 -ARs differently affect the degree of intracellular cAMP generation and, consequently, the relaxed or contractile state of the uterus (Do Khac et al., 1986) . Molecular events that underlie these subtle changes in sensitivity of the smooth muscle to catecholamines may result from 1) the alteration of the ␣ 2A/D -/␣ 2B -subtypes expression pattern ; 2) the drastic changes of Gi 2 /Gi 3 protein ratio (Tanfin et al., 1991; Cohen-Tannoudji et al., 1995) ; and/or 3) the functional properties of the pregnant myometrium adenylyl cyclase population Suzuki et al., 1997) . As an initial approach, we investigated whether ␣ 2A/Dand ␣ 2B -AR subtypes could exert different regulatory roles on ␤ 2 -AR catalyzed cAMP production. To address this issue, DDT1-MF2 cells provided an interesting context, because they endogenously express some of the molecular entities (␤ 2 -AR, Gi 2 , Gi 3 , and G s proteins) involved in myometrium ␣ 2 -/␤ 2 -AR cross talk but lack ␣ 2 -AR subtypes and AC type II isoform. Thus, we separately expressed ␣ 2B -or ␣ 2A/D -AR subtype in this cell line and, further on, cotransfected each clone with the adenylyl cyclase II isoform that potentiated cAMP production in response to ␣ 2 -AR agonists in pregnant myometrium. Selected clonal cell lines with comparable functional pools of ARs and adenylyl cyclase have provided useful test models for a careful examination on how ␣ 2 -AR differ in their ability to modulate adenylyl cyclase and to couple to endogenous Gi protein.
In this context, we found that, without any ACII expression, clonidine induced an inhibition of ␤ 2 -dependent cAMP production in both ␣ 2A -and ␣ 2B -AR transfectants (at 1 M clonidine ␣ 2A/D -and ␣ 2B-AR transfectants: 34 Ϯ 3% for and 62 Ϯ 2% rspectively). This result is consistent with those reported by Duzic and Lanier (1992) in the same cell line, demonstrating that ␣ 2B -and ␣ 2A/D -AR activation similarly inhibits forskolin-induced increase in intracellular cAMP. When AC II was coexpressed in DDT1-MF2-␣ 2A/D transfectants, epinephrine as well as clonidine were able to switch the inhibitory signal into a stimulatory input through PTXsensitive G proteins. In DDT1-MF2-␣ 2B -AC II cotransfectants, despite a similar functional pool of AC II and an equivalent density of receptor, clonidine was unable to trigger such a switch, in contrast with epinephrine. Direct measurement of G protein activation by photoaffinity labeling with [␣-
32 P]AA-GTP followed by selective separation of individual G protein ␣ subunits revealed that clonidine, acting on ␣ 2B -AR, mediated an exclusive coupling to Gi 2 , whereas the full agonist, epinephrine, led to the recruitment of both PTXsensitive G proteins, Gi 2 and Gi 3 . Thus, using this photoaffinity probe, it seems clear that, in DDT1-MF2 cells overexpressing AC II, the ability of ␣ 2B -AR to switch from a negative to a positive input to Gs-stimulated cAMP production greatly depends on the recruitment of Gi 3.
Previous works have established that the potentiation of Gs-stimulated cAMP production is caused by the input of G␤␥ released from Gi to AC II that synergizes with Gs to further elevate cAMP levels (Tang and Gilman, 1991; Federman et al., 1992) . Nevertheless, this phenomenon can only occur from a threshold concentration of released Gi␤␥ (Tang and Gilman, 1991) . Thus, the persistent inhibitory effect observed when Gi 2 is activated alone could be explained by the following hypothesis: the total amount of Gi 2 ␤␥ released upon receptor activation would be insufficient to overcome inhibitory influences exerted by Gi␣ 2 on endogenous AC. On the contrary, when both Gi proteins (Gi 2 and Gi 3 ) were recruited, the threshold concentration would be reached, thus allowing AC II potentiation. Here, we should note that the possibility of overcoming G␣i 2 inhibition was probably reinforced by the low ability of Gi␣ 3 to induce AC inhibition (Raymond et al., 1993; Gettys et al., 1994) . This might also reflect the fact that Gi 2 ␤␥ dimers released upon ␣ 2B -AR activation poorly interact or activate AC II compared with Gi 3 ␤␥. Although there is no direct evidence that Gi 2 ␤␥ and Gi 3 ␤␥ differ in their capacity to potentiate Gs-stimulated AC, such a hypothesis must be taken into account. Indeed, several studies report that the regulation of ␤␥-sensitive effectors depends on the composition of the G␤␥ dimers with which they are interacting (Mü ller et al., 1997; Bayewitch et al., 1998; Maier et al., 2000) . Finally, because post-translational modifications are considered important criteria in determining the potency by which G␤␥ complexes modulate effectors (Ford et al., 1998) , differential modifications of Gi 2 ␤ and/or -␥ versus Gi 3 ␤ and/or -␥ might also contribute to the clonidine-specific effect.
The present work also brings some evidence as to whether changes in the ratio of Gi 2 to Gi 3 proteins in late pregnant myometrium may play a crucial role for the switch in the stimulatory versus inhibitory input to AC population from the ␣ 2 -AR/Gi protein signaling. The down-regulation of Gi 3 protein, together with Gi 2 -increased expression , could prevent ACII potentiation, thus allowing the decrease of ␤ 2 -AR stimulated cAMP production at term. The inhibition of the synthesis of smooth muscle relaxation factor (cAMP) together with the increase of intracellular Ca 2ϩ would promote myometrial contractions at term.
In summary, these data provide the molecular basis of clonidine partial agonist effect when acting through ␣ 2B -AR, because they reveal that this compound selectively uncouples the receptor from one of the normally targeted G proteins: Gi 3 . From this finding, it can be predicted that, in the situation where clonidine behaves as the full agonist, the second messenger pathway would be exclusively regulated by Gi 2 in Gi 2 /Gi 3 expressing cells. On the other hand, in systems in which clonidine acts as partial agonist or even as an antagonist, Gi 3 would play a determinant or exclusive role. Furthermore, they suggested that Gi 2 and Gi 3 have specific roles in modulating AC II effector through ␣ and/or ␤␥ subunits. Finally, they shed light upon a possible molecular mechanism that might allow the versatility of signal routed through myometrial ␣ 2 -AR during pregnancy involved changes in Gi 2 /Gi 3 ratio.
